Recently, glioma cell-derived EVs have also been shown to express CD39 and CD73 and are able to metabolize ATP to adenosine, which plays a role in antitumor immune suppression and tumor progression [129,130]. The gene discussed is ENTPD1; the disease is neoplasm.